Le Lézard
Classified in: Science and technology
Subject: SVY

Harvard Business Review Analytic Services, in association with CI&T, Release New Report Entitled Machine Learning: The Next Generation of Customer Experience


NEW YORK, April 17, 2019 /PRNewswire/ -- CI&T, a leading global digital solutions partner announced the availability of a new Harvard Business Review Analytic Services report, in association with CI&T entitled "Machine Learning: The Next Generation of Customer Experience." The report outlines a shift toward a more pragmatic and approachable application of machine learning and its value within the customer journey to create real solutions that meet customer needs?immediately.

"We are in an important transition point with machine learning, especially now that it's out of the lab and in the enterprise delivering real and practical results today," said Lucas Persona, Chief Digital Evangelist at CI&T. "In a customer-centric approach, companies big and small can use machine learning to create proactive experiences that reveal new business models, products and services, and additional revenues. Contrary to popular belief, this can be done inexpensively without significant investment."

The report provides a new perspective on machine learning applied to the customer journey, sharing insights on how it can offer valuable results that directly improve the experience of a company's ultimate target?the customer. Additional highlights include:

"The time to start enhancing the customer experience with machine learning is now," said Alex Clemente, managing director of HBR Analytic Services. "Leaders are starting to cross the bridge from testing and learning to mainstream deployment. Companies that fail to take this important next step in their customer data and analytics journey may soon find themselves at a competitive disadvantage."

The link to the full report can be found here.

About CI&T:

For over 20 years, CI&T has been a trusted partner for the most complex engagements inside the world's biggest companies. We're experts at transforming the customer experience with the power of machine learning. As a Google Cloud Premier Partner since 2012, we accelerate the impact machine learning can bring to organizations and customers by reimagining their experience and validating the business impact within a short timeframe. With over 2,500 digital business strategists, designers and engineers in North America, APJ, LATAM, and Europe CI&T is big enough to scale to the needs of Fortune 100 clients yet agile enough to achieve the speed-to-market today's customers demand.

Learn more about CI&T: www.ciandt.com

PR Contact
Benny To
Illume PR for CI&T
310.452.4446
ciandt@illumepr.com 

 

SOURCE CI&T


These press releases may also interest you

at 20:09
The global integrated passive device market is accounted to US$ 820.6 Mn in 2018 and is expected to grow at a CAGR of 8.3% during the forecast period 2019 - 2027, to account to US$ 1,647.8 Mn by 2027. The global integrated passive device market is...

at 20:05
The precision medicine and biotechnology company Macrogen (CEO Kap-Seok Yang, www.macrogen.com/en/) announced on April 24 that it had signed a supply contract with Exosome Plus (CEO Jong-Uk Bu, www.exosomeplus.com) on...

at 20:00
MGID was named the winner of two Silver Stevie® Awards in the sixth annual Asia-Pacific Stevie® Awards. MGID won the Silver Stevie® Award for Innovation in Technology Development (Other Service Industries division) and the Silver Stevie® Award for...

at 20:00
Today, 52-year-old green manufacturer Earth Friendly Products®, the maker of ECOS® plant-powered cleaners, celebrated the 49th anniversary of Earth Day at its corporate headquarters in Cypress, California, by premiering a short video that is...

at 19:24
ComTec Solutions LLC has been awarded a Top Workplaces 2019 honor by The Democrat and Chronicle. The list is based solely on employee feedback gathered through a third-party survey administered by research partner Energage, LLC, a leading provider of...

at 19:16
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the first patient in China has been successfully dosed in a Phase I clinical...



News published on 17 april 2019 at 13:44 and distributed by: